Is Autologous Serum a Tonic for the Ailing Corneal Epithelium?

American Journal of Ophthalmology

Volumn 142, Issue 2, 2006, Pages 316-317

  Pflugfelder, Stephen C ^a  

^a CULLEN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL TEAR; HYALURONIC ACID;

BLOOD AUTOTRANSFUSION; CATARACT; CATARACT EXTRACTION; CLINICAL TRIAL; CORNEA DISEASE; CORNEA EPITHELIUM; EDITORIAL; EYE SURGERY; HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SURGICAL TECHNIQUE; VITRECTOMY;

DIABETIC RETINOPATHY; EPITHELIUM, CORNEAL; EYE INJURIES; HUMANS; HYALURONIC ACID; SERUM; VITRECTOMY; VITREORETINOPATHY, PROLIFERATIVE; WOUND HEALING;

EID: 33746322506     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2006.05.002     Document Type: Editorial

References (15)

1. Schulze S., Sekundo W., and Kroll P. Autologous serum for the treatment of corneal epithelial abrasions in diabetic patients undergoing vitrectomy. Am J Ophthalmol 142 (2006) 207-211
2. Tsubota K., Goto E., Shimmura S., and Shimazaki J. Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology 106 (1999) 1984-1989
3. Poon A.C., Geerling G., Dart J.K., et al. Autologous serum eye drops for dry eyes and epithelial defects. clinical and in vitro toxicity studies. Br J Ophthalmol 85 (2001) 1188-1197
4. Ferreira de Souza R., Kruse F.E., and Seitz B. Autologous serum for otherwise therapy resistant corneal epithelial defects-Prospective report on the first 70 eyes. Klin Monatsbl Augenheilkd 218 (2001) 720-726
5. Vajpayee R.B., Mukerji N., Tandon R., et al. Evaluation of umbilical cord serum therapy for persistent corneal epithelial defects. Br J Ophthalmol 87 (2003) 1312-1316
6. Young A.L., Cheng A.C., Ng H.K., et al. The use of autologous serum tears in persistent corneal epithelial defects. Eye 18 (2004) 609-614
7. Pflugfelder S.C., Stern M.E., and Beuerman R. Dysfunction of the integrated functional unit-impact on tear film stability and composition. In: Pflugfelder S.C., Stern M.E., and Beuerman R. (Eds). Dry eye and the ocular surface (2004), Marcel Dekker, New York 63-88
8. Azar D.T., Spurr-Michaud S.J., Tisdale A.S., and Gipson I.K. Altered epithelial-basement membrane interactions in diabetic corneas. Arch Ophthalmol 110 (1992) 537-540
9. Ljubimov A.V., Huang Z.S., Huang G.H., et al. Human corneal epithelial basement membrane and integrin alterations in diabetes and diabetic retinopathy. J Histochem Cytochem 46 (1998) 1033-1041
10. Azar D.T., Spurr-Michaud S.J., Tisdale A.S., and Gipson I.K. Decreased penetration of anchoring fibrils into the diabetic stroma. A morphometric analysis. Arch Ophthalmol 107 (1989) 1520-1523
11. Geerling G., Maclennan S., and Hartwig D. Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol 88 (2004) 1467-1474
12. Sato Y., Katajiri F., Inoue S., et al. Effects of Sho-hange-ka-bukuryo-to and Nichin-to on levels of calcitonin gene-related peptide and substance P in human plasma. Biol Pharm Bull 27 (2004) 2032-2034
13. Nagano T., Nakamura M., Nakata K., et al. Effects of substance P and IGF-1 in corneal epithelial barrier function and wound healing in a rat model of neurotrophic keratopathy. Invest Ophthalmol Vis Sci 44 (2003) 3810-3815
14. Higuchi A., Shimmura S., Takeuchi T., et al. Elucidation of apoptosis induced by serum deprivation in cultured conjunctival epithelial cells. Br J Ophthalmol (2006) Forthcoming
15. Sauer R., Bluthner K., and Seitz B. Sterility of non-preserved autologous serum drops for treatment of persistent corneal epithelial defects. Ophthalmologe 101 (2004) 705-709